Neuroanesthesia and Liver Disease

  • Gargi Banerjee
  • Kevin Piepsney
  • Shobana Rajan


In a patient with liver disease coming for an intracranial procedure, the clinician should keep in mind the pathophysiology of the liver disease while planning a strategy for controlling the intracranial pressure. Maintaining the cerebral perfusion pressure in a patient with a compromised cerebrovascular reserve is a challenge.

The prime issues in neuroanesthesia that an anesthesiologist is required to tackle are brain relaxation, hyperventilation, arterial blood pressure management, use of steroids, osmotherapy, diuretics, anticonvulsant use, patient positioning, intraoperative blood loss, and intravenous fluid management. The prime concerns in a patient with liver disease include coagulation problems, malnutrition, potential ascites, abnormal metabolism of drugs, pulmonary hypertension, high cardiac output and a low systemic vascular resistance state, bleeding from esophageal varices, potential for hepatorenal syndrome, and hepatic encephalopathy.


  1. 1.
    Moller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut. 2008;57:268.CrossRefGoogle Scholar
  2. 2.
    Schepke M, Heller J, Paschke S, et al. Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: evidence for a receptor-specific mechanism. Hepatology. 2001;34:884.CrossRefGoogle Scholar
  3. 3.
    Palma DT, Fallon MB. The hepatopulmonary syndrome. J Hepatol. 2006;45:61.CrossRefGoogle Scholar
  4. 4.
    Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome–a liver-induced lung vascular disorder. N Engl J Med. 2008;358:2378–87.CrossRefGoogle Scholar
  5. 5.
    Rodriguez-Roisin R, Krowka MJ, Herve P, et al. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J. 2004;24:861–80.CrossRefGoogle Scholar
  6. 6.
    Joist JH. AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state. Am J Gastroenterol. 1999;94:2801–3.CrossRefGoogle Scholar
  7. 7.
    Frink EJ, Morgan SE, Coetzee A, et al. The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs. Anesthesiology. 1992;76:85–90.CrossRefGoogle Scholar
  8. 8.
    Hunter JM, Parker CJ, Bell CF. The use of different doses of vecuronium in patients with liver dysfunction. Br J Anaesth. 1985;57:758–64.CrossRefGoogle Scholar
  9. 9.
    Magorian T, Wood P, Caldwell J, et al. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg. 1995;80:754–9.PubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Gargi Banerjee
    • 1
  • Kevin Piepsney
    • 2
  • Shobana Rajan
    • 2
  1. 1.K. C. Roy Memorial HospitalRanchiIndia
  2. 2.Cleveland ClinicClevelandUSA

Personalised recommendations